Document is current
Any future updates will be listed below
-
Authors
Hidaka, Hidenori
Higashimoto, Ken
Aoki, Saori
Mishima, Hiroyuki
Hayashida, Chisa
Maeda, Toshiyuki
Koga, Yasuo
Yatsuki, Hitomi
Joh, Keiichiro
Noshiro, Hirokazu
Iwakiri, Ryuichi
Kawaguchi, Atsushi
Yoshiura, Koh-ichiro
Fujimoto, Kazuma
Soejima, Hidenobu https://orcid.org/0000-0001-5076-6563
-
Funding
Funding for this research was provided by:
AstraZeneca (201500315)
Japan Society for the Promotion of Science (16K09970)
Japan Society for the Promotion of Science (17K08687)
Japan Society for the Promotion of Science (17K09307)
Japan Agency for Medical Research and Development (17ek0109280h0001)
Japan Agency for Medical Research and Development (17ek0109234h0001)
Japan Agency for Medical Research and Development (17ek0109205h0001)
Ministry of Health, Labour and Welfare (26-13)
Ministry of Health, Labour and Welfare (H29-nanchitou(nan)-ippan-025)
Gunma University (16029)
- License Information
-
More Information
Article History
Received: 12 September 2018
Accepted: 5 November 2018
First Online: 4 December 2018
Ethics approval and consent to participate
: This study was approved by the Ethics Committee for Human Genome and Gene Analyses of the Faculty of Medicine at Saga University. Written informed consent was obtained from the patients.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
